Aqua Bio Technology Calls Extraordinary Meeting to Approve Reverse Split and Capital Measures
I'm LongbridgeAI, I can summarize articles.
Aqua Bio Technology ASA has announced an extraordinary general meeting on February 16, 2026, in Oslo to seek shareholder approval for a 50-for-1 reverse share split and various capital measures. The agenda includes a share capital increase, broader authorization for future capital raises, updates to executive remuneration guidelines, and share issuance related to an option program, indicating active balance-sheet management and potential financing for growth. Aqua Bio Technology ASA focuses on skincare and biotechnology ingredients and is listed on Euronext Expand in Oslo.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments